Pregnancy outcomes in women using inhaled fluticasone during pregnancy: a case series / Evolución del embarazo en mujeres que usaron fluticasona inhalada durante el mismo: una serie de casos
Allergol. immunopatol
; 35(6): 239-242, nov. 2007. tab
Artigo
em En
| IBECS
| ID: ibc-058247
Biblioteca responsável:
ES1.1
Localização: ES1.1 - BNCS
ABSTRACT
Background:
The aim of the study was to report the maternal and fetal outcomes of women with respiratory illnesses who were treated with inhaled fluticasone during pregnancy. Material andmethods:
We identified 12 cases treated with inhaled fluticasone during pregnancy out of women who received obstetric and teratogen-risk evaluation at the Korean Motherisk Program. A detailed medical and obstetric history was obtained and cases were followed-up until either spontaneous or voluntary pregnancy termination or delivery occurred.Results:
None of the participants had any obstetric complication. However, in addition to fluticasone, most of the 12 cases were simultaneously exposed to a variety of medications. There were 3 abortions (one spontaneous and 2 requested by the patients arguing personal reasons). Live born babies without any evidence of major congenital malformations included 8 singleton babies and 2 twins. Of them, 3 babies were born prematurely.Conclusions:
Our results are in agreement with previous large studies where no increased rate of adverse outcomes was reported with the use of inhaled corticosteroids during pregnancyRESUMEN
Objetivo:
la finalidad de este estudio fue conocer la evolución de la madre y el feto de aquellas mujeres afectas de enfermedad respiratoria que fueron tratadas con fluticasona inhalada durante el embarazo. Material ymétodos:
se estudiaron 12 mujeres que durante el embarazo estaban en tratamiento con fluticasona inhalada, a las que se evaluó el riesgo teratógeno de acuerdo con el Programa Coreano de Riesgo Materno. Se obtuvo una historia clínica y obstétrica detallada y los casos se siguieron hasta la terminación espontánea o voluntaria del embarazo.Resultados:
ninguna de las pacientes tuvo complicaciones obstétricas. Sin embargo, además de la fluticasona, la mayoría de las pacientes estuvieron expuestas simultáneamente a una variedad de medicamentos. Hubo 3 abortos (uno espontáneo y 2 a requerimiento de las pacientes que arguyeron razonas personales). Los recién nacidos vivos (de ellos, dos fueron gemelos y tres prematuros) no mostraron ninguna evidencia de malformaciones congénitas.Conclusiones:
estos resultados están de acuerdo con estudios previos amplios en los que no se observó un incremento de efectos adversos por el uso de corticosteroides inhalados durante el embarazo
Buscar no Google
Coleções:
Bases de dados nacionais
/
Espanha
Base de dados:
IBECS
Assunto principal:
Complicações na Gravidez
/
Asma
/
Nebulizadores e Vaporizadores
/
Beclometasona
/
Corticosteroides
/
Teratologia
Tipo de estudo:
Estudo prognóstico
Limite:
Adulto
/
Feminino
/
Humanos
/
Gravidez
Idioma:
Inglês
Revista:
Allergol. immunopatol
Ano de publicação:
2007
Tipo de documento:
Artigo
Instituição/País de afiliação:
Hospital for Sick Children/Canadá
/
Kwandong University College of Medicine/Corea
/
PharmaReasons/Canadá